GenSight Biologics: results on Lumevoq® gene therapy -March 12, 2024 at 05:42 am EDT marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Sustained efficacy three years after injection: statistically significant visual acuity improvement from nadir Continuous benefits in bilaterally treated patients with +17 to +20 ETDRS letters
Emory faculty and staff are frequently recognized for their work locally, nationally and internationally. Read a sampling of recent accolades, including awards for professional contributions and leadership appointments.
Gene therapy delivered by intravitreal injection can counter visual degeneration associated with Leber hereditary optic neuropathy, new phase 3 trial data suggest.